,outcome,arm 1,arm 2
0,intervention,risperidone-treated subjects,placebo-treated subjects
0,"study endpoint, improvement over baseline in the irritability score",64 %,NR
0,"study endpoint, 64 %, improvement over baseline in the irritability score",31 %,31 %
